2021: A Year in Review at Indica Labs
As 2021 draws to a close, the team at Indica Labs would like to take this opportunity to reflect on the year and to thank our customers for their continued support through this second pandemic year. Despite the ongoing challenges that the pandemic presents, we celebrate the achievements of our customers who have published over 250 publications in peer-reviewed journals this year with an impressive average impact factor of 9.12. To learn more about these publications spanning immuno-oncology, oncology, immunology, infectious disease, and neurology, read our high-impact publications guide and visit our Literature page.
This year represented a milestone for Indica Labs, as we are celebrating the 10th anniversary since our CEO, Steven Hashagen, founded the company with the vision of advancing digital pathology image analysis algorithms. Today, Indica Labs employs over 80 people including scientists, IT professionals, software developers and engineers in the US, China, Japan, UK, and Europe. Indica Labs continues to grow organically and new hires span R&D roles, Technical Solutions, Applications and Sales Support, Marketing, Pharma Services, and our Artificial Intelligence (AI) team.
At Indica Labs, we are proud to be named a 2021 top workplace by the Albuquerque journal for the second year in a row and to have received the work/life flexibility award. “2020 was a challenging year for everyone across the world, and to be named a Top Workplace for our second year is a huge accomplishment,” said Steven Hashagen, CEO at Indica Labs. “We are told throughout our working life that work/life balance is important, but the pandemic brought that message home for many of us. We are especially proud to receive the Work/Life Flexibility Award this year and are committed to nurturing this balance within our company culture, now and into the future.
In 2021, Indica Labs announced a new partnership with IBEX to deliver AI-powered clinical workflows for digital pathology in May. “While Indica Labs continues to grow our state-of-the-art AI application pipeline, we also recognize the importance of interoperability with other leaders in this growing field,” commented Steven Hashagen, Indica Labs CEO. “A truly seamless integration with Ibex will allow customers to make best-of-breed AI selections without compromising usability.”
In addition, Indica Labs added Visikol, a BICO Company, as a comarketing partner this past year and we look forward to continued collaboration with the Visikol team in 2022!
This year at Indica Labs, we launched the 3.3 version of HALO, HALO AI, and HALO Link and we are getting ready to release the 3.4 versions soon! If you missed our HALO, HALO AI, and HALO Link 3.4 Sneak Peek webinar, consider watching it on-demand to learn more about the upcoming release features.
In July of 2021, we were delighted to announce together with Nottingham University Hospitals NHS Trust the selection of Indica Labs to deliver their digital pathology solution with our clinical product, HALO AP. Also, in November we launched the 1.3 release of HALO AP that enabled a new ergonomic viewing mode. Learn more about additional features in our HALO AP 1.3 Sneak Peek webinar.
We were fortunate to be able to host an in-person user group meeting in London this year with a focus on bench-to-bedside workflows for digital pathology, image analysis, and AI. Our speakers presented on topics as diverse as lean implementation of clinical digital pathology to analysis of colorectal cancer and utilization of multiplexed immunofluorescence analysis in contract research.
We hosted eight webinars presented by customers on topics ranging from H. pylori driven preneoplastic progression to CD38 in the prostate tumor microenvironment. We also presented nine masterclass webinars, four Product Showcase webinars, and participated in 3 Xtalks webinars. Check out the webinars section on the News and Events to watch recordings of these webinars.
In addition, we sponsored a DigiBase Spatial Biology event titled Revolutionizing Tissue Imaging and Analysis with Spatial Profiling this past September. If you missed this event, you can view the recording on demand that featured a fantastic lineup of speakers.
This year, we made significant upgrades to our Learning Portal to make content more readily available and easy to locate. If you are a customer and haven’t signed up for our Learning Portal, register today for access to educational materials including webinars, tutorial videos, release notes, administration guides, white papers, application notes, and more.
Also in 2021, we’ve released several notable resources, including an RNAscope image analysis white paper and a case study featuring how the NIH uses HALO Link for the COVID-19 Digital Pathology Repository. If you don’t receive our newsletters and would like to keep in touch with our latest releases, events, and customer support materials, we invite you to sign up now.
LOOKING FORWARD TO 2022
In 2022, we’ll be announcing new versions of our life science and clinical digital pathology software platforms that continue to expand features and functionality. We are really excited about the 4.0 releases of HALO, HALO AI, and HALO Link 4.0 that will be coming out mid-year so stay tuned on these major releases! Our Pharma Services team is expanding and busier than ever, so please reach out if you would like to learn more about our image analysis services offering.
We are looking forward to hosting more customer events and user group meetings, some of which may be in-person and some virtual. We hope you sign up for our newsletter, visit our News and Events page, and follow us on Twitter and LinkedIn to stay up to date on the latest announcements from Indica Labs.
Thanks again to everyone who has supported Indica Labs this year! We look forward to working with you in 2022.